Skip to main content

Table 2 Antifungal susceptibility testing of T. mycotoxinivorans isolated in 2012 (Morphotype 1 and Morphotype 2) and 2013

From: A case report of a cystic fibrosis patient with repeated isolation of Trichosporon mycotoxinivorans identified by a novel short-extraction method

  s503348/2012 s503348/2012 s503026/2013
Morphotype 1 Morphotype 2  
Antifungal agent MICa MICa MICa
Amphotericin B 0.5 2.0 0.25
Anidulafungin >8.0 >8.0 >8.0
Micafungin >8.0 >8.0 >8.0
Caspofungin >8.0 >8.0 >8.0
Flucytosine 16 32.0 64
Posaconazole 0.06 0.25 0.12
Voriconazole 0.03 0.12 0.03
Itraconazole 0.015 0.25 0.03
Fluconazole 2.0 8.0 4.0
  1. aMIC minimal inhibitory concentration expressed in mg/l